ALLERGAN INC·4

Apr 27, 8:15 PM ET

ROSSO LOUIS T 4

4 · ALLERGAN INC · Filed Apr 27, 2005

Insider Transaction Report

Form 4
Period: 2005-04-25
Transactions
  • Award

    Phantom Stock Units

    2005-04-25$72.98/sh+13.7$1,00022,119.9 total
    Common Stock (0 underlying)
  • Award

    Phantom Stock Units

    2005-04-26$73.01/sh+27.39$2,00022,160.99 total
    Common Stock (0 underlying)
Footnotes (3)
  • [F1]Converts to common stock on a 1-for-1 basis.
  • [F2]Phantom stock units acquired under the Allergan, Inc. Deferred Directors' Fee Program in lieu of cash for meeting fees.
  • [F3]Phantom stock units are to be settled 100% in stock upon the reporting person's retirement as an Allergan, Inc. director.

Documents

1 file
  • 4
    ros374.xmlPrimary